证券记录 · 已归档季度
ADMA
ADMA Biologics, Inc. · Healthcare · Biotechnology
19被追踪持有人
+1Δ持有人
92.34M持有股份
$1.35B报告持仓市值
+3新建仓位
−3清仓
动量输入（同类管理人）：
持有人广度 +5.6% ·
股份流向 -2.5% ·
净新建仓位 0.0%
· 公式
持有人分散化：持有人数增多，合计持仓比例缩小。
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 57.02K | $424,202 | n/a | n/a |
| Q2 2026 | 105 | -1 | 146.16M | $1.22B | +9 | −12 |
| Q1 2026 | 111 | -5 | 163.83M | $1.48B | +7 | −12 |
| Q4 2025 | 115 | +1 | 163.64M | $2.98B | +1 | n/a |
| Q3 2025 | 19 | +1 | 92.34M | $1.35B | +3 | −3 |
| Q2 2025 | 16 | -1 | 89.41M | $1.63B | +1 | −2 |
| Q1 2025 | 14 | 0 | 31.71M | $629.12M | n/a | n/a |
| Q4 2024 | 14 | +2 | 37.00M | $634.64M | +2 | n/a |
| Q3 2024 | 11 | -2 | 23.86M | $476.89M | n/a | −2 |
| Q2 2024 | 13 | n/a | 23.97M | $268.00M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 35.63M | -2.3% | $522.36M | 0.0% | ▼ Trim | 2 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (被动) | 20.97M | -1.8% | $307.49M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (被动) | 13.56M | +12.3% | $198.81M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 5.81M | -1.7% | $85.24M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 5 | Goldman Sachs Group ✦ | 2.91M | n/a | $42.67M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 6 | Renaissance Technologies ✦ | 2.77M | -11.9% | $40.61M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 2.16M | +0.8% | $31.60M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Citadel Advisors ✦ | 2.12M | 新增 | $31.07M | 0.0% | New | 1 | SEC ↗ ×2 |
| 9 | Morgan Stanley ✦ | 1.46M | n/a | $21.38M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 10 | Point72 Asset Management ✦ | 1.32M | 新增 | $19.38M | 0.0% | New | 1 | SEC ↗ |
| 11 | JPMorgan Chase ✦ | 923.40K | n/a | $13.54M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 12 | Two Sigma Investments ✦ | 898.03K | -25.3% | $13.17M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 732.66K | -77.2% | $10.74M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 14 | D. E. Shaw & Co. ✦ | 332.70K | -60.0% | $4.88M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | Millennium Management ✦ | 284.84K | -74.9% | $4.18M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 275.16K | -40.2% | $4.03M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 17 | Wellington Management ✦ | 103.30K | -88.9% | $1.51M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 18 | Bridgewater Associates ✦ | 60.28K | 新增 | $883,734 | 0.0% | New | 1 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 11.01K | -89.9% | $161,421 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Citadel Advisors | $31.07M | 0.0% |
| Point72 Asset Management | $19.38M | 0.0% |
| Bridgewater Associates | $883,734 | 0.0% |
已清仓
| Arrowstreet Capital | $6.57M | 曾为 0.0% |
| Norges Bank | $548,722 | 曾为 0.0% |
| Marshall Wace | $384,048 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 355 持有人, 211.31M 股份, $1.84B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据